Model Number 1550250-15 |
Device Problems
Failure to Advance (2524); Contamination /Decontamination Problem (2895)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/30/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
The device was received and the investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
|
|
Event Description
|
It was reported that on (b)(6) 2021, a percutaneous intervention was performed on the circumflex and marginal coronary arteries.The xience sierra stent delivery system had failed to cross due to anatomy.The device was removed without issue and additional dilatation was performed.Once outside the anatomy, an unknown string fiber/wire was noted on the stent's proximal end.There was no foreign object left in the anatomy.The patient had no adverse event associated with this issue.A guideliner was placed and another xience sierra was successfully used in replacement without further issues.No additional information was provided regarding this issue.
|
|
Manufacturer Narrative
|
The device was returned for analysis.The reported contamination was confirmed.The reported failure to advance could not be replicated in a testing environment as it was related to operational context of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported failure to advance appears to be related to circumstances of the procedure as it is likely the device interacted with the difficult anatomy causing the reported failure to advance.A conclusive cause for the reported contamination could not be determined as chemical analysis indicates the unknown string was polytetrafluoroethylene (ptfe).Manufacturing engineering indicated this type of material and shape is not used on the xience sierra manufacturing lines.It is possible the contamination was attached to the stent after removal from the anatomy.It should be noted contamination was not noted on the stent delivery system (sds) during the inspection prior to use, which suggests a product quality issue did not contribute to the reported difficulties.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
Search Alerts/Recalls
|